-
1
-
2
-
3
-
4
-
5دورية أكاديمية
الإتاحة: https://doi.org/10.1016/j.eclinm.2024.102485Test
https://pure.eur.nl/en/publications/a7db5a71-fa40-4803-a57d-7d6b5caff1afTest
https://pure.eur.nl/ws/files/137219533/Improving_survival_in_advanced_melanoma_patients.pdfTest
http://www.scopus.com/inward/record.url?scp=85185705698&partnerID=8YFLogxKTest -
6دورية أكاديمية
الإتاحة: https://doi.org/10.1002/cncr.35178Test
https://pure.eur.nl/en/publications/1c351dca-74af-4f82-b1da-51255a48e6ebTest
https://pure.eur.nl/ws/files/126123983/BRAF_MEK_inhibitor_rechallenge_in_advanced_melanoma_patients.pdfTest
http://www.scopus.com/inward/record.url?scp=85181942238&partnerID=8YFLogxKTest -
7دورية أكاديمية
الإتاحة: https://doi.org/10.1007/s11764-022-01306-9Test
https://pure.eur.nl/en/publications/67892186-e5ac-4e21-a30a-286f1ebf9290Test
https://pure.eur.nl/ws/files/79463073/Living_in_the_twilight_zone_a_qualitative_study_on_the_experiences_of_patients_with_advanced_cancer_obtaining_long_term_response_to_immunotherapy_or_targeted_therapy.pdfTest
http://www.scopus.com/inward/record.url?scp=85143633994&partnerID=8YFLogxKTest -
8
-
9
-
10